ChinaBio® Executive Workshop
Doing Business in the United States: Practical Steps for Success in the World’s Largest Life Sciences Market
Hosted by: Foley & Lardner LLP
Date: June 13, 2011 (Wednesday)
Location: Grand Hyatt Shanghai
Time: 08:30 --- 12:00
Foley and ChinaBio invite you to join us for our upcoming workshop, “Doing Business in the United States: Practical Steps for Success in the World’s Largest Life Sciences Market.” This seminar is specifically designed for executives and in-house legal counsel for Chinese life sciences companies with some experience doing business in the United States who are interested in learning practical steps to increase their U.S. presence and sales.
Topics to be discussed include:
- Overview of China’s life sciences industry and Chinese life sciences companies doing business in the United States
- Strategies for entering the U.S. market — strategic alliances, joint ventures, direct investment, and other collaborations
- Practical strategies for reducing patent pendency and managing patent prosecution costs in the United States
- Post-grant patent issues, reducing patent litigation cost, and other risk management issues in the United States
|8:30 - 9:00
||Registration and Breakfast
|9:10 - 9:40
||Overview of China’s life sciences industry and Chinese life sciences companies doing business in the United States
- Greg B. Scott, President and Founder, ChinaBio® LLC
|9:40 - 10:20
||Strategies for entering the U.S. market — strategic alliances, joint ventures, direct investment, and other collaborations
- James C. Chapman, Partner, Foley & Lardner LLP
|10:20 - 10:40
|10:40 - 11:20
Practical strategies for reducing patent pendency and managing patent prosecution costs in the United States
|11:20 - 12:00
||Post-grant patent issues, reducing patent litigation cost, and other risk management issues in the United States
- Andrew S. Baluch, Special Counsel, Foley & Lardner LLP
|12:00 - 12:30
Andrew Baluch, JD - Intellectual Property Special Counsel, Foley & Lardner LLP
Andrew Baluch is an Intellectual Property law special counsel with Foley & Lardner LLP. He advises companies on global IP strategies, including international portfolio management, IP diligence reviews, opinions, licensing, litigation, patent reexamination, and trade secret protection. As a member of the firm's China practice, Mr. Baluch provides clients with information on the impact of the Chinese legal environment and consultancy on U.S. law and international conventions, including the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) and the Anti-Counterfeiting Trade Agreement (ACTA). Mr. Baluch is a former director of international IP enforcement in the White House Office of the IP Enforcement Coordinator. Prior to his White House appointment, he was an expert legal advisor to the under secretary and director of the U.S. Patent & Trademark Office (USPTO).
James C. Chapman, JD, MBA - Partner, Foley & Lardner LLP
James C. Chapman is a partner with Foley & Lardner LLP where he focuses on securities law, venture capital, mergers and acquisitions, and international business transactions. Mr. Chapman has more than 20 years experience in corporate and securities law and has been involved in over 200 mergers, acquisitions, and financing transactions. These transactions have included public offerings, private placements, debt financings, venture capital transactions, stock sales, asset sales, mergers, reorganizations, and recapitalizations. He is a member of the firm’s Private Equity & Venture Capital Practice and the Emerging Technologies Industry Team.
James F. Ewing, JD, PhD - Partner, Foley & Lardner LLP
James F. Ewing is vice chair of the Chemical, Biotechnology & Pharmaceutical Practice and a member of the Life Sciences, Food and Nanotechnology Industry Teams. Dr. Ewing primarily advises pharmaceutical, biotechnology, and nutraceutical clients. In the pharmaceutical and biotechnology sectors, Dr. Ewing works with companies engaged in drug discovery to develop and produce peptide and small molecule therapeutics, encompassing such technologies as computationally assisted drug design, immunology and vaccine technologies, stem cell technologies, neurobiology, drug delivery, gene therapy technologies, nanobiology technologies and biomedical devices.
Greg B. Scott - President and Founder, ChinaBio® LLC
Greg Scott is an entrepreneur, angel investor and business advisor who has helped launch over thirty life science companies in the U.S. and China. He founded ChinaBio® LLC in January 2007 to bring together Chinese and Western life science companies to better leverage China’s rapidly growing market. ChinaBio works with U.S. and European companies seeking partners, acquisitions and novel technologies in China. ChinaBio has also organized over 20 conferences in China focused on investment and partnering, and is holding its fourth ChinaBio Partnering Forum in Suzhou in May, 2012. This international event draws over 700 attendees from around the world. Greg is also the president and co-founder of Life Science Angels, an angel investment group that has funded over 44 biotechnology and medical device companies in the U.S. and China since 2005, and Executive Editor of the ChinaBio® Today newsletter, the most widely read source for China life science news. Greg lives and works in Shanghai but visits the U.S. several times a year to enjoy California’s blue sky and sandy beaches.
This ChinaBio® Executive Workshop – Shanghai will be held at:
Grand Hyatt Shanghai (??????) ?????
Conference Room I, 1F
Address: Jin Mao Tower, 88 Century Avenue, Pudong, Shanghai
200121, China Local Map
Tel: +86 21 5049 1234
- From Shanghai Pudong International Airport, 45 min, 180 RMB (one way)
- From Shanghai Hongqiao International Airport, about 45 min, 110 RMB (one way)
- From the Shanghai Railway Station, about 30min, 50 RMB (one way)
For driving directions, please contact the hotel.
We would like to thank Foley & Lardner for hosting this seminar:
- Foley & Lardner LLP – Foley is a highly regarded, international law firm providing client-focused, industry-specific services that result in high-value legal counsel for our clients. Our practice areas encompass the full range of corporate legal services. With an office located in Shanghai, the attorneys of Foley’s China Practice are well positioned to assist U.S., Asian, and European clients with the complex matters that arise when doing business in or related to Greater China. From IP procurement and technology transfer to M&A due diligence, count on Foley’s experience and our cultural and business connections in China to help you stake you claim. www.foley.com
We would also like to thank the following partners for making this event possible:
- BayHelix – BayHelix is an organization of leaders of Chinese origin in the global life sciences and healthcare community. We aspire to shape the growth of the life sciences and healthcare industry around the Pacific Rim and beyond, foster and create business opportunities, supply and nurture the leaders for the community, and network and share information and experience. BayHelix is a non-profit organization and its membership is by-invitation-only. www.bayhelix.org
- Bioon – Bioon are the leading life science portal in China. And professional registered members have more than 500 thousand; special 70% members are the master's -and doctoral qualifications. Our enterprises’ customers are more than 11 thousand, such as Invitrogen, Promega, Qiagen, Sigma, Pall. As the leading service- provider in China, we are committed to enhance the competition of our customers in life sciences. The following pipelines are our mature businesses: (1) www.bioon.com commitment to the field of life sciences media and brand promotion; (2) www.bioon.com.cn focused on our customers’ products -promotion, display and rankings, such as equipments, consumables, reagents and antibodies; Addition, we collected and sorted the serial of databases -including China lab database, professor database and region -based registered members database. These databases are the strong support and tool for customers marketing activity and marketing survey & analysis. Now, Bioon.com has become the preferred options to life sciences’ customers for professional seminar & training, targeting product promotion, brand -improvement and marketing survey & analysis. of professional customers in China. www.bioon.com
- ChinaBio® Today – China has surpassed Japan the second largest pharmaceutical market in the world, and is growing at an astounding 22% per year. Now, after billions of dollars of government and private investment, China is transforming itself into a world leader in biotechnology. ChinaBio® Today is the most widely read source focusing exclusively on China’s rapidly evolving life science industry, with over 18,000 readers. From our offices in Shanghai and San Diego, we provide daily news, commentary and analysis on public and private China life science companies, as well as global issues affecting the China market. www.ChinaBioToday.com.
About ChinaBio® LLC
Since its founding in January, 2007, ChinaBio® LLC has rapidly launched a number of initiatives accelerating the globalization of China’s life science industry. ChinaBio has helped China companies raise nearly $400 million and global life science companies identify over 400 licensing and acquisition opportunities in China.
- Conferences: ChinaBio organizes the premier life science investment and partnering conferences in China, having attracted over 4,000 attendees.
- Consulting: ChinaBio works with global life science companies and China entrepreneurs to define and execute a successful global strategy.
- Transactions: ChinaBio Capital helps companies secure partnerships and acquisitions and access private and government funding in China.
- Publishing: ChinaBio® Today is the most widely read online and email newsletter on China’s life science industry.
More information is available at www.ChinaBioLLC.com.